Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Budesonide/formoterol versus salbutamol for rapid bronchodilation in adults with asthma
ACTRN12619001387112Phase 3Terminated
- Sponsor
- Medical Research Institute of New Zealand
- Start
- Jan 2020
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of budesonide and salbutamol in asthma (2 arms), sponsored by Medical Research Institute of New Zealand. Primary endpoint: FEV1 measured by spirometry. Started Jan 2020; status: terminated.
02
Drugs
budesonidesalbutamol
03
Conditions
asthma
Beyond the preview
Go deeper on ACTRN12619001387112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619001387112.